PMV Pharmaceuticals, Inc.PMVPNASDAQ

Revenue (LTM)

Net Income (LTM)

$-78M

-32.4% YoY

Free Cash Flow

$-74M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	-1	-1↑49.3%	-1↓93.4%	-1↑9.0%	-0↑88.4%
Operating Income	-58	-77↓32.2%	-80↓4.0%	-85↓6.6%	-86↓0.9%
Net Income	-58	-73↓26.7%	-69↑5.9%	-59↑14.9%	-78↓32.4%
EBITDA	-57	-73↓28.5%	-68↑6.8%	-74↓8.8%	-86↓17.0%
EPS Diluted	-1.28	-1.61↓25.8%	-1.44↑10.6%	-1.14↑21.0%	-1.48↓30.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	172	108↓37.2%	38↓65.2%	41↑8.4%	38↓7.1%
Total Current Assets	301	247↓18.0%	207↓16.0%	176↓15.3%	115↓34.4%
Total Assets	332	270↓18.5%	252↓6.7%	191↓24.1%	117↓39.1%
Total Current Liabilities	12	11↓11.4%	14↑29.5%	14↑2.4%	11↓20.6%
Total Liabilities	23	24↑5.5%	26↑9.0%	15↓42.5%	12↓22.1%
Total Equity	309	246↓20.3%	226↓8.3%	176↓22.0%	105↓40.5%
Total Debt	11	14↑24.9%	13↓4.9%	1↓91.0%	1↓29.6%
Net Debt	-161	-94↑41.5%	-24↑74.1%	-40↓62.5%	-37↑6.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-47	-64↓36.9%	-56↑12.7%	-51↑7.9%	-74↓43.5%
Capital Expenditure	-1	-8↓491.8%	-1↑88.0%	-1↑31.9%	-0↑95.6%
Free Cash Flow	-48	-72↓49.7%	-57↑21.1%	-52↑8.3%	-74↓41.7%
Stock-Based Comp	0	0	12	9↓28.3%	6↓33.2%
Net Change in Cash	-188	-64↑65.9%	-71↓10.0%	2↑103.3%	-3↓223.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance